하이퍼코퍼레이션

065650KOSDAQ기계장비 및 관련 물품 도매업

51.1 / 100

Reference Date: 2026-06-10

Financial Score7.0 / 40

News Sentiment17.1 / 25

Momentum15.0 / 20

Disclosure12.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Surged 40.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Hyper Corporation operates three main business divisions: Commerce, Biopharma, and Tech. The Commerce division sells PC peripherals and household products, while the Biopharma division develops innovative drugs, including anti-inflammatory treatments, Alzheimer's therapies, and a non-opioid painkiller (MDR-652). The company is expanding its market through new ventures like the early dementia diagnostic kit QPLEX Alz Plus and the EcoVacs brand, driving revenue growth.

Number of Employees

83people

Average Salary

33.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 10.164.0Point

PBR

2.11Industry Average 0.640.0Point

3.3x industry avg (risky)

ROE

-4.61Industry Average 2.780.0Point

Well below industry avg

Debt Ratio

39.24Industry Average 6.760.0Point

5.8x industry avg (risky)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲21.3% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼159.7% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -103.0% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 2Neutral 0Negative 1Average Sentiment Score 68.3

Positive
하이퍼코퍼레이션, 더블트리 바이 힐튼 서울 판교와 F&B 상품권 출시
하이퍼코퍼레이션의 더블트리 바이 힐튼 서울 판교와의 제휴로 카카오톡 선물하기 플랫폼에 호텔 다이닝 상품권이 출시되어 소비자 편의성이 향상되었다.
Negative
[유상증자 모니터] 주주에 손 벌린 하이퍼코퍼레이션, 재무 개선 과제
하이퍼코퍼레이션의 대규모 유상증자에도 불구하고 지속적인 영업적자와 현금흐름 악화로 인해 주주들에게 부담이 가중되고 있다.
Positive
하이퍼코퍼레이션, 200억원 주주배정 유상증자 결정
하이퍼코퍼레이션의 주주배정 유상증자 결정으로 자금 조달 성공 가능성이 높아져 긍정적인 시장 반응 예상.

Detailed Momentum

52-week position3.0Point

52w lower range (29%)

Current 2,955Won52-week high 6,09052-week low 1,654

1-month return6.0Point

1m +40.05% (strong rise)

Volume trend6.0Point

Volume surge

Detailed Disclosure

14 totalPositive 1Neutral 13Negative 0

Neutral주권매매거래정지해제 (액면병합 주권 변경상장)2026-06-08
Neutral주주총회소집결의2026-06-05
Neutral주주명부폐쇄기간또는기준일설정2026-06-05
Neutral정정신고서제출요구( 2026.05.13. 제출 증권신고서(지분증권) )2026-05-28
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-14